1Department of Pathology, Harvard Medical School, Boston, Massachusetts.
Cyclosporine is a powerful immunosuppressant approved for organ transplant recipients to prevent rejection. Research is exploring its potential use in bone marrow transplant patients to suppress graft-versus-host disease, indicating broader therapeutic applications.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: